NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation. Issue 1 (6th December 2018)

• Record Type: Journal Article
• Authors: Leone, Francesca; Gigliotti, Paolo; La Russa, Antonella; Lofaro, Danilo; Perri, Anna; Vizza, Donatella; Lupinacci, Simona; Toteda, Giuseppina; Bonofiglio, Martina; Presta, Pierangela; Talarico, Roberta; Aquino, Benedetta; Bonofiglio, Renzo
• Is Part Of: Transplant infectious disease. Volume 21:Issue 1(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-12-06
• Subjects: cytomegalovirus infection -- NFKB1 polymorphism -- preemptive therapy -- renal transplantation; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13027
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Introduction: Cytomegalovirus (CMV) infection represents a common cause of morbidity and mortality in kidney transplant recipients (KTR). The NF‐kB signaling pathway is highly involved in the pathogenesis of CMV infection. The ‐94ins/delATTG functional polymorphism in the promoter of NFKB1 has been associated with low intracellular levels of the protein and high incidence of inflammatory and autoimmune disease. In this study, we evaluated the association of this NFKB1 polymorphism with the risk of CMV infection. Methods: CMV infection was defined as virus isolation or detection of viral antigens or nucleic acid in any body fluid or tissue specimen. Using Cox regression and survival analysis, we analyzed the association between the polymorphism and CMV infection as well as recurrence in the first 12 months after transplantation. Results: We analyzed the ‐94ins/delATTG NFKB1 polymorphism of 189 KTRs. The 65% of CMV infections occurred in ins/ins group. Survival free from CMV infection was 54.7% for ins/ins group and 79.4% for deletion carriers one year after transplantation ( P < 0.0001). At multivariate regression, deletion carriers showed a lower risk of CMV infection and recurrence with respect to ins/ins KTRs (HR = 0.224 P = 0.0002; HR = 0.307, P = 0.012, respectively). Conclusions: In conclusion, pretransplantation screening for NFKB1 ‐94ins/delATTG polymorphism may predict CMV infection and improve the management of patients at higher risk of infection in the post‐transplant period.